Advanced Practice Providers Oncology Summit.

Bispecific Therapy in Cancer Treatment

Immunotherapy has changed the cancer treatment landscape and the development of bispecific antibodies shows promising results in hematologic malignancies, specifically non-Hodgkin lymphoma and multiple myeloma. During this webcast, expert faculty will provide an overview of bispecific antibodies and their role in therapy, including currently approved agents and toxicity profile.

Claudia Martin Diaz, PharmD, BCPS, BCOP / Alyssa Donadio, PharmD, BCPS, BCOP

Credit Hours: 1.0 AMA PRA Category 1 Credit™ 1.0 ANCC

Course Expires: 1.19.2025

Similar Courses To Consider